Page last updated: 2024-10-19

melatonin and Cortical Lewy Body Disease

melatonin has been researched along with Cortical Lewy Body Disease in 5 studies

Research Excerpts

ExcerptRelevanceReference
"Patients with rapid eye movement sleep behavior disorder are frequently prone to sleep-related injuries and should be treated to prevent injury with either melatonin 3-12 mg or clonazepam 0."2.55REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies. ( Boeve, AR; Boeve, BF; St Louis, EK, 2017)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
St Louis, EK1
Boeve, AR1
Boeve, BF1
Hershey, LA1
Coleman-Jackson, R1
Raggi, A1
Neri, W1
Ferri, R1
Pillai, JA1
Leverenz, JB1
Serrano, C1
García-Borreguero, D1

Reviews

5 reviews available for melatonin and Cortical Lewy Body Disease

ArticleYear
REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies.
    Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:5

    Topics: Central Nervous System Depressants; Clonazepam; GABA Modulators; Humans; Lewy Body Disease; Melatoni

2017
Pharmacological Management of Dementia with Lewy Bodies.
    Drugs & aging, 2019, Volume: 36, Issue:4

    Topics: Age Factors; Aged; Anticonvulsants; Antiparkinson Agents; Cholinesterase Inhibitors; Clinical Trials

2019
Sleep-related behaviors in Alzheimer's disease and dementia with Lewy bodies.
    Reviews in the neurosciences, 2015, Volume: 26, Issue:1

    Topics: Alzheimer Disease; Animals; Behavior; Humans; Lewy Body Disease; Melatonin; Sleep; Sleep Wake Disord

2015
Sleep and Neurodegeneration: A Critical Appraisal.
    Chest, 2017, Volume: 151, Issue:6

    Topics: Alzheimer Disease; Dementia; Humans; Lewy Body Disease; Melatonin; Multiple System Atrophy; Neurodeg

2017
Fluctuations in cognition and alertness in Parkinson's disease and dementia.
    Neurology, 2004, Oct-26, Volume: 63, Issue:8 Suppl 3

    Topics: Awareness; Central Nervous System Stimulants; Cholinesterase Inhibitors; Cognition Disorders; Dement

2004